TLDR Vertiv posted Q1 adjusted EPS of $1.17, beating the $1.00 consensus by $0.17 Revenue hit $2.65 billion, up 30% year-over-year, edging past estimates Full-yearTLDR Vertiv posted Q1 adjusted EPS of $1.17, beating the $1.00 consensus by $0.17 Revenue hit $2.65 billion, up 30% year-over-year, edging past estimates Full-year

Vertiv (VRT) Stock Slides After Revenue Forecast Fails to Impress Wall Street

2026/04/22 19:36
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

TLDR

  • Vertiv posted Q1 adjusted EPS of $1.17, beating the $1.00 consensus by $0.17
  • Revenue hit $2.65 billion, up 30% year-over-year, edging past estimates
  • Full-year revenue guidance midpoint of $13.75 billion came in below Wall Street’s $13.7 billion consensus
  • Full-year adjusted EPS guidance raised to $6.30–$6.40, well above the $6.16 consensus
  • Stock dropped over 5% in pre-market trading despite the earnings beat

Vertiv Holdings (VRT) delivered a strong first quarter on paper, but the market wasn’t impressed. The stock fell more than 5% in pre-market trading on Wednesday after the company’s full-year revenue outlook landed below what analysts were hoping for.


VRT Stock Card
Vertiv Holdings Co, VRT

Q1 adjusted EPS came in at $1.17, beating the $1.00 consensus by $0.17. Revenue reached $2.65 billion, up 30% from $2.04 billion in Q1 2025, and nudged past the $2.63 billion estimate.

The Americas region was the clear standout, posting organic sales growth of 44%, driven by strong data center demand.

Adjusted operating margin expanded 430 basis points to 20.8%. Adjusted free cash flow jumped 147% year-over-year to $653 million.

Revenue Guidance Disappoints

Despite the strong quarter, Vertiv’s full-year revenue guidance is where things got tricky. The company guided for fiscal 2026 revenue of $13.5 billion to $14 billion — a midpoint of $13.75 billion that sits just above the $13.7 billion analyst consensus, though some reports suggest it fell short of certain expectations on Wall Street.

On the earnings side, Vertiv raised its full-year adjusted EPS guidance to $6.30–$6.40, with a midpoint of $6.35 — well ahead of the $6.16 consensus. That’s a meaningful raise, but the revenue picture overshadowed it.

For Q2, the company sees revenue of $3.25 billion to $3.45 billion and adjusted EPS of $1.37 to $1.43, implying year-over-year EPS growth of 44% to 51% at the midpoint.

Analyst and Insider Activity

The analyst community remains broadly supportive. BNP Paribas Exane initiated coverage in April with an “outperform” rating and a $345 price target. Barclays raised its target to $300 with an “overweight” rating. Of 26 analysts covering the stock, 21 rate it a Buy, four a Hold, and one a Sell.

Zacks did lower its rating from “strong-buy” to “hold” earlier this month, and Wall Street Zen made a similar move in March.

On the insider front, Director Edward Monser sold 77,294 shares in early March at an average of $245.49, cutting his position by over 82%. Chairman David Cote sold 40,000 shares in late February at $255.29. Insiders have sold nearly 490,000 shares worth over $123 million in the past quarter.

Institutional investors hold around 89.92% of the stock. VRT opened Wednesday at $311.77, with a 12-month range of $69.00 to $323.04.

The post Vertiv (VRT) Stock Slides After Revenue Forecast Fails to Impress Wall Street appeared first on CoinCentral.

시장 기회
The 7 Wanderers 로고
The 7 Wanderers 가격(7)
$0.00001739
$0.00001739$0.00001739
+1.69%
USD
The 7 Wanderers (7) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!